Dr. Kwan is a radiologist who specializes in interventional radiology for liver, colon, and rectal cancers.
My job is to serve as a guide for patients when forming a treatment plan that is best for them, given the specifics of their disease and their personal values and preferences. I am fortunate to work with a talented, dedicated multidisciplinary team of providers and have access to the latest technologies and treatments.
Interventional radiology, interventional oncology, primary and secondary liver cancers, uterine fibroid embolization
- Associate Professor, Department of Radiology, University of Washington School of Medicine
- Attending Interventional Radiologist, Seattle Cancer Care Alliance
- Medical Education: Yale University
- Medical Education: Stanford University School of Medicine
- Residency & Fellowship: University of California, San Francisco
- Master of Science: University of Washington School of Public Health
Read more about Dr. Kwan’s work.
Sharon Kwan, MD, had the dream of becoming a psychiatrist so that she could help patients at a time of great vulnerability. “In medical school, I ended up being drawn to radiology because of its cutting-edge technology and impact on health care,” she says. “Advanced imaging was literally transforming the practice of medicine. Diagnostic radiology was a great fit for my background in engineering, but I missed interacting with patients and the privilege of being actively involved in their care. Interventional radiology (IR) is the perfect fit for me because it incorporates the use of powerful imaging technology with direct patient care. I work with a wide variety of patients and diseases, including trauma patients with life-threatening bleeding, healthy women with fibroids, medically complex patients with advanced kidney and liver disease, and (of course) cancer patients."
Dr. Kwan believes that interventional oncology is one of the most challenging and exciting subspecialties within IR. “We can now offer minimally invasive therapies with impressive outcomes while allowing patients to maintain their quality of life. Interventional oncology has also opened up therapeutic options for patients who previously may have been told they had none. Unfortunately, many people in the world still may not know of or have access to these new therapies.”
When it comes to changes she hopes to see with cancer diagnosis, treatment, and prevention in her lifetime, Dr. Kwan hopes there will be greater public awareness of minimally invasive treatment options for cancer. “There are also great strides being made in targeted cancer therapies. The ultimate goal and one I hope to see in my lifetime would be treatments that can seek out cancer cells at a molecular level and effectively kill them, but result in no side effects to the patient. When that day comes, I will be gladly out of a job.”